- 30/10/2005 - Biotron's HIV drug improves activity of existing HIV therapies
- 25/10/2005 - Appendix 4C - Quarterly Report 30 September 2005
- 24/10/2005 - Directors' Interests
- 21/10/2005 - Options
- 14/10/2005 - Presentation to Annual General Meeting
- 14/10/2005 - Annual General Meeting
- 29/09/2005 - Annual Report for year ended 30 June 2005
- 13/09/2005 - Preliminary Final Report for year ended 30 June 2005
- 8/09/2005 - Lead HIV Drug Selected to Progress Into Human Trials
- 17/08/2005 - Biotron Compound Active Against Resistant HIV
- 15/08/2005 - Passing of Professor Peter Gage
- 28/07/2005 - Appendix 4C - Quarterly Report 30 June 2005
- 11/05/2005 - C-Test Project Developments
- 4/05/2005 - Virion Project Developments
- 21/04/2005 - Appendix 4C - Quarterly Report 31 March 2005
- 25/02/2005 - Half Year Financial Report 31 December 2004
- 28/01/2005 - Appendix 4C - Quarterly Report 31 December 2004
